skip to main content
 
 
 
News
In the News
Jun 15, 2017

Apotex Holdings Inc. completes sale of Accucaps Industries to Catalent Pharma Solutions

Share:
Lexpert Magazine View original

On February 16, 2017, Catalent Pharma Solutions Ltd. announced the completion of its purchase of all of the shares of Accucaps Industries Ltd. from Apotex Holdings Inc. for an undisclosed price. 

Accucaps is a developer and manufacturer of over-the-counter pharmaceutical softgels and operates two state-of-the art softgel development, manufacturing and packaging facilities in Windsor and Strathroy, Ont. The acquisition complements and enhances Catalent’s global network of 11 softgel technology facilities. 

Apotex Holdings Inc. was represented by Torkin Manes LLP, with a team led by Jeffrey Cohen and including Sammy Redlick and Adrian Myers.

To read the complete details in Lexpert Magazine, click here. 

Related News

In the News

Involve legal advisers early in corporate acquisition, sale process

For sellers, preparation is essential to success in a corporate merger and acquisition (M&A) transaction — and engaging advisers in the ear...
Jul 9, 2019
In the News

Sammy Redlick speaks to Advocate Daily about the warning signs companies need to steer clear of in the acquisition process

While profitability and a healthy balance sheet are often top of mind for companies looking at potential acquisition targets, they should also be...
Jun 17, 2019
In the News

GTY Technology acquires Bonfire Interactive Ltd., Questica Inc. and Questica USCDN Inc.

On February 19, 2019, GTY Technology Holdings Inc. (“GTY”), a special purpose acquisition company traded on the NASDAQ and which was formed to consumm...
Apr 2, 2019